Abstract:Background Ovarian cancer (OC) has the highest fatality rate amongst all gynecologic malignancies. Exploring new factors and pathways associated with development of ovarian cancer would help to identify new therapeutic targets. Long non-coding RNAs (lncRNAs) play indispensable roles in the process of the progression of OC. Methods Reverse transcription-quantitative PCR (RT-qPCR) was performed to verify the expression of RAD51B-AS1 in cell lines and patients’ tissues. Cellular proliferation, metastasis and apoptosis were detected using Cell Counting Kit-8(CCK-8), colony formation, Transwell and flow cytometry assays, respectively. Mouse xenograft models were established to detect tumorigenesis. RT-qPCR, western blotting and immunofluorescence experiments were conducted to explore the quantitative and positional relationship between RAD51B-AS1 and its host gene, RAD51B. Co-transfection rescue experiments were then performed to preliminarily explore its mechanism in vivo and in vitro. Results RAD51B-AS1 was significantly upregulated in a highly metastatic human OC cell line and in OC tissues. RAD51B-AS1 significantly increased the proliferation and metastasis of OC cells, whilst also enhancing resistance to anoikis. Biogenetics prediction analysis revealed that the only target gene of RAD51B-AS1 was RAD51B. Subsequent gene function experiments revealed that RAD51B exerted the same biological effects as RAD51B-AS1. Rescue experiments demonstrated that the malignant biological behaviors promoted by RAD51B-AS1 overexpressing were partially or completely reversed by RAD51B silencing in vitro and in vivo.Conclusion RAD51B-AS1 promoted the malignant biological behavior of OC, and the underlying mechanism of this action may be associated with the positive regulation of RAD51B expression. The present study revealed a potentially novel molecular mechanism underlying the development of OC. RAD51B-AS1 is expected to serve as a novel molecular biomarker for the diagnosis and prediction of a poor prognosis in OC, and as a potential therapeutic target for management of the disease.

LncRNA OIP5-AS1 Upregulates the Cyclin D2 Levels to Promote Metastasis of Breast Cancer by Targeting miR-150-5p

Long Noncoding RNA SNHG14 Promotes Breast Cancer Cell Proliferation and Invasion Via Sponging Mir-193A-3p

Downregulation of Long Non-Coding RNA MR4435-2HG Suppresses Breast Cancer Progression Via the Wnt/β-catenin Signaling Pathway.

LncRNA RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer via upregulation of RAD51B

Downregulation of Long Non‐coding RNA Opa Interacting Protein 5‐antisense RNA 1 Inhibits Breast Cancer Progression by Targeting Sex‐determining Region Y‐box 2 by Microrna‐129‐5p Upregulation

LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis

Long noncoding RNA CASC15 is upregulated in non-small cell lung cancer and facilitates cell proliferation and metastasis via targeting miR-130b-3p.

LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model

LncRNA CASC15 Functions As an Oncogene by Sponging Mir-130B-3p in Bladder Cancer.

A novel long non‐coding RNA LINC00524 facilitates invasion and metastasis through interaction with TDP43 in breast cancer

OIP5-AS1 contributes to the development in endometrial carcinoma cells by targeting miR-152-3p to up-regulate SLC7A5

LINC00882, Transcriptionally Activated by CEBP-β and Post-Transcriptionally Stabilized by METTL14-mediated M6a Modification, Exerts Tumorigenesis by Promoting PABPC1-mediated Stabilization of ELK3 Mrna

Long noncoding RNA HOTAIR promotes breast cancer development by targeting ZEB1 via sponging miR-601

LncRNA LINC00466 Promotes the Progression of Breast Cancer via miR-4731-5p/EPHA2 Pathway

Long noncoding RNA OPA‐interacting protein 5 antisense transcript 1 upregulated SMAD3 expression to contribute to metastasis of cervical cancer by sponging miR‐143‐3p

LINC01296/miR-141-3p/ZEB1-ZEB2 axis promotes tumor metastasis via enhancing epithelial-mesenchymal transition process

Molecular mechanism of miR-34b-5p and RNA binding protein HuR binding to lncRNA OIP5-AS1 in colon cancer cells

Long Non-coding RNA HOTAIR Function as a Competing Endogenous RNA for miR-149-5p to Promote the Cell Growth, Migration, and Invasion in Non-small Cell Lung Cancer

LINC00478-derived novel cytoplasmic lncRNA LacRNA stabilizes PHB2 and suppresses breast cancer metastasis via repressing MYC targets

LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway

LINC00882 , transcriptionally activated by CEBP-β and post-transcriptionally stabilized by METTL14-mediated m 6 A modification, exerts tumorigenesis by promoting PABPC1-mediated stabilization of ELK3 mRNA